The pharmaceutical weight management sector is experiencing remarkable transformation, propelled by rising global obesity statistics and increased healthcare provider adoption of medical weight loss therapies. Leading this market evolution are Novo Nordisk and Eli Lilly, two pharmaceutical giants engaged in aggressive competition for obesity therapeutics dominance. As GLP-1...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bangla